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Abstract DsbA is a periplasmic, disulfide bond formation factor 
of E. coll. We studied in vivo redox states of its active site 
cysteines. When periplasmic contents were prepared from io- 
doacetic acid-treated cells, according to the previously published 
procedures, variable but major proportions of DsbA were in the 
reduced form. We found that this was due to an artificial reduc- 
tion that occurred after cell disruption; even purified and oxidized 
l)sbA underwent reduction when incubated with cell extracts in 
the absence of any added reducing agent. Such DsbA-reducing 
activities were detected in both the periplasmic and the cytoplas- 
mic fractions. To circumvent the artifact, we analyzed redox 
states of DsbA under denaturing conditions. Now virtually all the 
DsbA molecules were detected as oxidized or reduced in the 
dsbB + background or in the dsbB-  background, respec- 
tively. Using the improved method, we also examined redox states 
of DsbA when it was overproduced, and followed the oxidation/ 
reduction pathway that DsbA follows after biosynthesis. It is 
suggested that newly synthesized DsbA is rapidly oxidized by 
pre-existing DsbA, while oxidation of mature (functional) DsbA 
requires DsbB, whose roles might include that of antagonizing the 
actions of DsbA-reducing enzyme(s). 
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1. Introduction 
Many proteins that are secreted to the cell surfaces contain 
disulfide bonds, which are important for their folding and sta- 
bility. Escherichia coli and other prokaryotic cells contain a 
specific 'Dsb' system, which facilitates disulfide bond formation 
in the periplasmic space (for review see [1]). Mutational inacti- 
vation of either the dsbA [2,3], dsbB [4,5], or dsbC [6] gene 
pleiotropically impairs disulfide bond formation of envelope 
proteins. DsbA and DsbC are soluble proteins of the periplasm, 
while DsbB is a membrane protein with four transmembrane 
segments [7]. They all possess a Cys-X-X-Cys moti f  character- 
istic of active sites seen for the members of the thioredoxin 
superfamily [8]. Among these factors, the DsbA protein has 
been characterized in considerable detail [9 12]. It directly oxi- 
dizes secretory proteins. DsbB probably re-oxidizes the reduced 
form of DsbA to enable it to work again [4,7]. Little is known 
about DsbC, which may function in a pathway independent of 
the DsbA/DsbB pathway [6]. 
Biochemical and biophysical studies suggested that the oxi- 
dized form of DsbA is in an unstable conformation [10,11]. In 
apparent consistency with this notion, Bardwell et al. detected 
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only a fraction of DsbA molecules in the wild-type cell as the 
oxidized form [4]. In the experiment of Bardwell et al., they 
fractionated the cells in the presence of iodoacetic acid and 
examined the periplasmic preparation by electrophoresis under 
non-denaturing conditions. We now show that such a method 
can not be used for assessing DsbA's redox states in vivo, since 
DsbA is subject to artificial reduction by some cellular pro- 
tein(s) once cells are disrupted for fractionation. Instead, our 
re-examinations of the intracellular redox states of DsbA under 
denaturing conditions showed that DsbA molecules in wild- 
type cells are mostly oxidized. Examination of the redox states 
of overproduced DsbA revealed two modes of its oxidation; 
one that takes place for the newly synthesized molecules and 
another for the maintenance of the steady state. Possible signif- 
icance of the DsbA-reducing factor(s) and the roles of DsbB in 
keeping DsbA oxidized are discussed. 
2. Experimental 
2. l. Bacterial stra&s and plasmids 
Escherichia coli K 12 strain CU 141 [13] is a derivative o f MC4100 and 
carries F' lacI Q lacZ+Y+A +lacPL8. SS141 is a CUI41 derivative into 
which dsbB :: kan5 [4] had been transduced. SS 140 is a dsbA33:: Tn5 [2] 
derivative of CU141. pSK220, carrying a 1.2 kb chromosomal fragment 
of the dsbA region, was described previously [2]. Another dsbA plasmid, 
pSS18, was constructed by cloning the 1.0 kb EcoRI HindllI fragment 
of the pUC19-derived sbA ÷ plasmid [14] into pMW119, a pSCI01- 
based vector provided by Nippon Gene. 
2.2. Determination of redox states of DsbA & vivo 
A culture of cells growing in L medium [15] at 37°C was mixed with 
an equal volume of 10% trichloroacetic a id. Precipitates of denatured 
proteins were pelletted by centrifugation (microfuge for 2 min), washed 
with acetone, and dissolved in 1% SDS, 1 mM EDTA, 50 mM Tris-HC1 
(pH 8.1) containing 5 mM iodoacetamide. Proteins were then separated 
by 12.5% SDS-PAGE [16] without addition of any reducing agent. 
DsbA was visualized by immunoblotting as described previously [9]. In 
some experiments, trichloroacetic acid-denatured proteins were dis- 
solved in 6.4 M urea, 1.5 M Tris-HCl (pH 8.7), containing 100 mM 
iodoacetic acid. The sample was then diluted 4-fold with 1.5 M Tris- 
HC1 (pH 8.7) and electrophoresed under non-denaturing conditions 
[4,10]. Finally, the procedures described by Bardwell et al. [4] were also 
followed; iodoacetic acid was added to the culture, and cells were 
subjected to osmotic shock to obtain the periplasmic fraction, which 
was then analyzed by native PAGE. Anti-DsbA serum was described 
previously [9]. 
2.3. Preparation of periplasm and ~Ttoplasm fractions and demonstration 
of DsbA-reducing activities 
Cells were grown in L medium at 37°C, and fractionated by osmotic 
shock [17] or lysozyme-EDTA-sucrose tr atment [18]. Shocked cells 
were resuspended in 10 mM Tris-HCl (pH 8.1) and then disrupted by 
sonication. After centrifugation at540,000 x g for 30 min, the superna- 
tant was used as the cytoplasmic extract. As an indication of separation 
of the periplasmic fraction from the cytoplasmic material, the distribu- 
tion of GroEL was examined as described [13]. DsbA, purified from 
overproducing cells, was in the oxidized state [9]. It was mixed with 
varying amounts of each subcellular f action, and incubated at 0°C for 
60 min, followed by SDS-PAGE under non-reducing conditions. 
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2.4. Pulse-chase and immunoprecipitation 
Cells were grown at 37°C in synthetic medium M9 [15] supplemented 
with glucose (0.4%) and amino acids (20 ¢tg/ml each, except methionine 
and cysteine), pulse-labeled with 3.7 MBq/ml of [35S]methionine (29 
TBq/mmol; obtained from American Radiolabeled Chemicals). Chase 
with unlabeled methionine was initiated by addition of 200 ~tg/ml 
L-methionine. Immunoprecipitation conditions were as previously 
described [2]. 
3. Resu l ts  and d iscuss ion 
3.1. Redox states of DsbA in vivo can only be assessed under 
denaturing conditions 
In order to examine redox states of DsbA in vivo, Bardwell 
et al. [4] treated the culture with iodoacetic acid and prepared 
the periplasmic fraction. The redox states of DsbA were then 
examined by native PAGE, in which the reduced and oxidized 
forms can be separated by the charge difference due to the 
modification of the reduced cysteines by iodoacetic acid [10]. 
Less than 50% of DsbA molecules in wild-type cells were oxi- 
dized, while all of them were reduced in the dsbB::kan5 cells 
[4]. Using the same procedures, we obtained results that were 
basically consistent with the results of Bardwell et al., but some- 
what variable from experiment to experiment; in many cases as 
much as about 90% of DsbA was detected as reduced even in 
the wild-type cells (Fig. 1B, lanes 1 and 2). 
We employed an alternative procedure in which cultures 
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Fig. 1. Redox states of DsbA in vivo as determined by different meth- 
ods. (A) Cells of CU141 (wild-type; lanes 1 and 3) and SS141 
(dsbB::kan5; lanes 2 and 4) were treated irectly with trichloroacetic 
acid (lanes 1 and 2), or fractionated in the presence of 10 mM iodoacetic 
acid [4] to obtain periplasmic fractions which were then treated with 
trichloroacetic acid (lanes 3 and 4). Proteins were solubilized in SDS 
sample buffer without reducing agent but with iodoacetamide and sepa- 
rated by SDS-PAGE under non-reducing conditions. DsbA was visu- 
alized by immunoblotting, red and ox represent reduced and oxidized 
DsbA, respectively. (B) Cells of CUI41 (lanes 1, 3, and 5) or SS141 
(lanes 2, 4, and 6) were subjected to the following treatments. Lanes 1 
and 2: periplasmic fractions were prepared in the presence ofiodoacetic 
acid. Lanes 3 and 4: cultures were treated with iodoacetic acid at room 
temperature for 10 min and then with trichloroacetic a id, followed by 
solubilization of proteins in urea. Lanes 5 and 6: samples were treated 
as described for lanes 3 and 4 except hat the final urea solubilization 
was carried out in the presence of 100 mM iodoacetic acid. Samples 
were diluted and analyzed by PAGE under non-denaturing conditions 
[10] and immunoblotting, redl and red2 represent DsbA in which only 
Cys 3° was modified by iodoacetic acid and that with both Cys 3° and 
Cys 33 residues modified, respectively [10]. 
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Fig. 2. Periplasmic fraction contains a factor(s) that reduces DsbA in 
vitro. Periplasmic fractions were prepared from CU141 (wild-type; 
lanes 2 and 3 of A and lanes 2~, of B) or SS140 (dsbA ::Tn5; lanes 5 
and 6 of A and lanes 5-7 of B). Purified and oxidized DsbA (0.2 ,ug) 
was incubated, in a final volume of 50 gl of 3 mM Mops (pH 7), with 
3 mM iodoacetic acid and the following amounts of periplasmic prep- 
arations: lanes 1 and 4 of A as well as lane 1 of B, none; lanes 2 and 
5 of A, a culture-equivalent of 0.4 ml; lanes 3 and 6 of A, a culture- 
equivalent of 1.6 ml; lanes 2 and 5 of B, a culture-equivalent of 0.45 
ml; lanes 3 and 6 of B, a culture quivalent of 1.35 ml. Redox states of 
DsbA were analyzed either by non-reducing SDS-PAGE (A) or native 
PAGE (B). 
were directly treated with trichloroacetic acid to denature and 
precipitate all the cellular proteins, which were subsequently 
solubilized in SDS in the presence of iodoacetamide or io- 
doacetic acid. Upon SDS-PAGE under non-reducing condi- 
tions, DsbA protein from the wild-type cells migrated istinctly 
faster than that from the dsbB::kan5 cells (Fig. 1A, compare 
lanes 1 and 2). The former and the latter species represented 
oxidized and reduced forms as they migrated identically after 
reduction (data not shown). The successful detection of only 
the reduced form of DsbA in the dsbB mutants (Fig. 1A, lane 
2) indicates that oxidation of cysteines did not occur during our 
in vitro manipulations of the samples. 
We also used native PAGE for separation of various species 
of DsbA to show that our results were independent of the 
method of electrophoretic separation. We treated cultures first 
with iodoacetic acid and then with trichloroacetic acid, and 
protein precipitates were solubilized in urea and subjected to 
native PAGE. DsbA in the wild-type cell migrated mostly in the 
oxidized form (Fig. 1B, lane 3), while that in the dsbB::kan5 
cells was reduced since its accessible cysteine [10] had been 
modified (see the redl band of Fig. 1 B, lane 4). When iodoacetic 
acid was added at the point of urea solubilization, DsbA from 
the wild-type cells remained oxidized (Fig. 1B, lane 5), while 
that from the dsbB:: kan5 cells underwent modification of both 
of the two cysteine residues (see the red2 band of Fig. 1 B, lane 
6). Full accessibility of denatured DsbA to the iodoacetic acid 
modification was previously reported [10]. 
We found that initially oxidized DsbA was reduced during 
cell fractionation under non-denaturing conditions. When the 
same cells as used in lane 1 of Fig. IA were fractionated to 
obtain the periplasmic preparation, DsbA that was otherwise 
identically processed was detected as the reduced form (Fig. 
IA, lane 3). 
These results establish that most, if not all, of DsbA mole- 
cules are oxidized in the periplasm of the wild-type cells. The 
S. Kishigami et al./FEBS Letters 364 (1995) 55-58 57 
1 2 3 4 
dsbB + 
Fig. 3. Redox states of overproduced DsbA in the presence or absence 
of DsbB. Cells of CUI41/pSK220 (lane 1), SS141 (dsbB::kan5) (lane 
2), and SS141/pSS18 (lanes 3 and 4) were grown at 37°C in amino 
acid-supplemented M9 medium with 0.4% glucose (lanes 2 and 3) or 
0.4% glycerol (lanes 1 and 4). Expression of dsbA was induced with 
5 mM isopropylthio-fl-D-galactoside for lanes 3 and 4. Redox states of 
DsbA were analyzed as described in Fig. IA. 
m 
apparent accumulation of the reduced form in the wild-type 
cells [4] must have been due to artificial reduction after disrup- 
tion of the cell. 
3.2. E. coli cell lysates contain factors that reduce DsbA in vitro 
To demonstrate DsbA reducing activities of cell extracts 
more directly, we incubated a purified and oxidized preparation 
of DsbA with periplasmic or cytoplasmic extracts. Examination 
by both SDS-PAGE (Fig. 2A) and native PAGE (Fig. 2B) 
showed that the oxidized form of DsbA was converted to the 
reduced form. The extent of the conversion was dependent on 
the amounts of added extract. It should be noted that no reduc- 
ing reagent had been added to either the medium or the buffers 
used. Although iodoacetic acid was added in the reactions re- 
ported in Fig. 2, reduction of purified DsbA, as assessed from 
profiles in non-reducing SDS-PAGE, did not depend on the 
presence of iodoacetic acid during the incubation (data not 
shown). The activity found with the periplasmic preparation 
was partially characterized; it was non-dialyzable, largely heat 
stable, and adsorbed to DEAE-Sepharose, from which it could 
be eluted with about 0.25 M NaCI (data not shown). The active 
material appears to be a protein(s). 
The DsbA-reducing activities did not quantitatively differ 
between the periplasm preparations prepared from the dsbA ÷ 
and the dsbA ::Tn5 cells (compare lanes 2/3 with lanes 5/6 of 
Fig. 2A as well as lanes 24  with lanes 5-7 of Fig. 2B). This, 
together with the fact that pretreatment of the periplasmic 
material with iodoacetic acid did not abolish the activity (Fig. 
1A, lane 3; Fig 1B, lane 1), indicates that reduction of DsbA 
was not due to fortuitous oxidation of cysteine residues that 
remained in some of periplasmic proteins. The same culture- 
equivalent amounts of periplasmic fraction and cytoplasmic 
fraction gave comparable activities of DsbA reduction (data 
not shown). The degree of contamination of the periplasmic 
fraction by the cytoplasmic material, as assessed by the distri- 
bution of GroEk, was less than 10%. The DsbA-reducing activ- 
ity did not change when a periplasmic preparation obtained by 
osmotic shock and that obtained after lysozyme-sucrose tr at- 
ment were compared (see [19] for the release of some cytoplas- 
mic proteins by osmotic shock). Thus, both the periplasm and 
the cytoplasm of E. coli appear to contain material active in 
DsbA reduction. The cytoplasmic activity might well be as- 
cribed to non-specific ysteine-containing proteins. However, 
evidence suggests that the periplasmic activity is not due to 
proteins with potential disulfide-bond forming cysteines. It re- 
mains to be investigated whether this activity is specific for 
DsbA or is due to a 'cross talk' with a system, like HelX of 
Rhodobacter capsulatus [20], which acts to keep other substrates 
reduced. 
3.3, Redox states of  overproduced DsbA 
We also examined redox states of DsbA that was overpro- 
duced from a plasmid. Substantial fractions of overproduced 
DsbA were shown to be in the reduced state (Fig. 3, lane 1). 
The reduced form of DsbA appeared to represent those mole- 
cules of DsbA that escaped from oxidation by DsbB; presuma- 
bly they were produced because DsbB had been overloaded by 
excess DsbA. 
Interestingly, when DsbA was overproduced extensively in 
the dsbB:: kan5 cells, a significant fraction of it was now oxi- 
dized in spite of the lack of the DsbB activity (Fig. 3, lane 4). 
This is striking since all DsbA molecules without hyperproduc- 
tion are reduced in the absence of DsbB (Fig. 3, lanes 2 and 3; 
[4]). We assume that two factors may have contributed to the 
appearance of the oxidized DsbA in the absence of DsbB. First, 
as shown below, every newly synthesized DsbA molecule might 
be oxidized before it assumes native conformation. Although 
this oxidation itself will depend on the DsbA/DsbB system, 
overproduced DsbA is known to partially compensate for the 
lack of the DsbB activity [4]. Secondly, overproduced and ex- 
cess DsbA may escape from the DsbA-reducing factor; thus, 
DsbA that is oxidized by air oxygen might be preserved. 
3.4. Pathways of  DsbA oxidation 
We then followed the process of biosynthesis of DsbA by 
pulse-chase xperiments. DsbA overproduced in either the 
dsbB + or dsbB:: kan5 cells was labeled, immunoprecipitated an  
analyzed by non-reducing SDS-PAGE. DsbA from wild-type 
cells was fully oxidized at the point of the 30 s pulse label and 
remained so during the chase (data not shown), indicating that 
DsbA is rapidly oxidized in vivo like other exported proteins 
[2,3,21]. 
In the case of overproduced DsbA, it was largely oxidized 
just after the pulse labeling (Fig. 4A, lane 1) and then gradually 
A dsbB + B dsbB - 
1 2 3 4 5 1 2 3 4 5 
re _ 
OX -- OX 
0 1 3 9 27 0 1 2 4 8 
chase  (ra in)  chase  (min)  
Fig. 4. Kinetics of oxidation/reduction of overproduced DsbA. Cells of CU141/pSK220 (A), or SSI41/pSK220 (B) were pulse-labeled for 30 s with 
[3SS]methionine, and chased with unlabeled methionine for the indicated periods. Samples were processed for immunoprecipitation of DsbA in the 
presence of iodoacetamide. After SDS-PAGE under non-reducing conditions, radioactive proteins were visualized by a Bioimaging Analyzer, 
BAS2000 (Fuji Film). 
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attained the steady-state r dox state (Fig. 4A, lanes 2 5), in 
which as much as about 60% was reduced. Thus, newly synthe- 
sized DsbA in the overproducing strain was initially oxidized 
and then reduced to the steady-state r dox state. 
As described in the preceding section, oxidized DsbA accu- 
mulates even under the dsbB-defective conditions, but this only 
happens when DsbA is extensively overproduced. Pulse-chase 
experiments shown in Fig. 4B indicate, however, that a signifi- 
cant fraction of DsbA that was moderately overproduced in the 
dsbB::kan5 mutant was oxidized just after biosynthesis (Fig. 
4B, lane 1) and then reduced (Fig. 4B, lane 5). 
We interpret these results as follows. During the processes 
of biosynthesis and export to the periplasm, DsbA molecules 
initially remain unfolded and behave as a substrate for the 
pre-existing DsbA enzyme, just as an ordinarily exported pro- 
tein does. Following the oxidation, the newly exported DsbA 
will be folded into the functional structure. The folded DsbA 
molecules then gain the ability to oxidize other newly exported 
proteins (with concomitant reduction of themselves), to interact 
with DsbB, and to interact with the DsbA-reducing factor(s). 
Thus, DsbA is oxidized in two different modes. The one that 
occurs for newly synthesized molecules is probably mediated 
by pre-existing DsbA, since it occurs even in the dsbB- cells 
(Fig. 4B, land 1). The other that occurs for mature DsbA 
should be mediated by DsbB. 
The present study revealed that the E. coli cell possesses 
factors that reduce DsbA. Although the activity of such factors 
only becomes apparent after disruption of the cell and conse- 
quent uncoupling of DsbA from DsbB, the factors (especially 
the one that resides in the periplasm) might have a role in 
regulating the redox state of DsbA. We propose that DsbB- 
mediated oxidation of DsbA will be important both to recycle 
back the reduced form of DsbA and to keep it oxidized by 
counteracting the reducing factor(s) in the periplasm. 
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